HomeAI · summaries
Storia in 8 fonti
Aussie super funds hit the jackpot in $2b UK biotech deal
Brandon Capital will receive more than $300 million from the sale of Myricx, which is developing cancer-killing “biological missiles”, to Swiss giant Novartis.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
afr.com
Aussie super funds hit the jackpot in $2b UK biotech deal
Brandon Capital will receive more than $300 million from the sale of Myricx, which is developing cancer-killing “biological missiles”, to Swiss giant Novartis.
- ·
morningstar.com
Correction to Novartis Article
Novartis will pay up to $400 million in potential additional payments. "Novartis to Buy Myricx Bio for Up to $1.5 Billion," at 0523 GMT, misstated the figure.
